Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Pulmatrix Inc (PULM)

1.62   -0.05 (-2.99%) 06-04 16:00
Open: 1.66 Pre. Close: 1.67
High: 1.67 Low: 1.58
Volume: 675,917 Market Cap: 41M
Pulmatrix Inc is is a clinical stage biotechnology company. The Company is engaged in discovery and development of a novel class of inhaled therapeutic products intended to prevent and treat respiratory diseases and infections.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.673 - 1.683 1.683 - 1.693
Low: 1.554 - 1.564 1.564 - 1.575
Close: 1.6 - 1.618 1.618 - 1.638

Technical analysis

as of: 2020-06-04 4:35:07 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.07     One year: 2.40
Support: Support1: 1.31    Support2: 1.09
Resistance: Resistance1: 1.77    Resistance2: 2.06
Pivot: 1.72
Moving Average: MA(5): 1.66     MA(20): 1.67
MA(100): 1.48     MA(250): 1.12
MACD: MACD(12,26): 0.06     Signal(9): 0.08
Stochastic oscillator: %K(14,3): 34.71     %D(3): 35.98
RSI: RSI(14): 49.85
52-week: High: 2.06  Low: 0.61  Change(%): 64.8
Average Vol(K): 3-Month: 114424  10-Days: 68293

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
PULM has closed above bottom band by 28.7%. Bollinger Bands are 16.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 14 May 2020
Pulmatrix Reports Q1 2020 Results - BioSpace

Wed, 20 May 2020
Pulmatrix Inc. [PULM] Stock trading around $1.72 per share: What’s Next? - The DBT News

Wed, 20 May 2020
Is Pulmatrix Inc (PULM) Stock a Great Value? - InvestorsObserver

Wed, 27 May 2020
Pulmatrix to Host 2020 Annual Meeting of Stockholders Virtually - PRNewswire

Wed, 13 May 2020
Are Investors Keen On Selling Holdings In Pulmatrix, Inc. (NASDAQ:PULM)? - Stocks Register

Tue, 12 May 2020
For Pulmatrix Inc. [PULM], H.C. Wainwright sees a rise to $5. What next? - The DBT News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 25
Shares Float (M) 22
% Held by Insiders 0.01
% Held by Institutions 18.86
Shares Short (K) 1,320
Shares Short P. Month (K) 1,070

Stock Financials

EPS -1.001
EPS Est This Year -4.130
EPS Est Next Year -4.480
Book Value (p.s.) 0.340
Profit Margin -188.59
Operating Margin -131.17
Return on Assets (ttm) -39.0
Return on Equity (ttm) -234.9
Qtrly Rev. Growth
Gross Profit (p.s.) -0.194
Sales Per Share 0.420
EBITDA (p.s.) -0.543
Qtrly Earnings Growth
Operating Cash Flow (M) 7
Levered Free Cash Flow (M) 6

Stock Valuations

PE Ratio -1.62
PEG Ratio
Price to Book value 4.76
Price to Sales 3.86
Price to Cash Flow 5.51

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.